HCW Biologics (HCWB) Minority Interest (2020 - 2021)
HCW Biologics' (HCWB) quarterly Minority Interest came in at $32.1 million in Q2 2021, up 3.18% on a QoQ basis from $31.1 million in Q4 2020.
HCW Biologics (HCWB) Minority Interest (2020 - 2021) Analysis & Trends
HCW Biologics (HCWB) has 2 years of Minority Interest data on file, last reported at $32.1 million in Q2 2021.
- Quarterly Minority Interest changed N/A year-over-year to $32.1 million in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $32.1 million (changed N/A YoY) and the FY2020 annual result came in at $31.1 million, changed N/A from the prior year.
- Minority Interest advanced to $32.1 million in Q2 2021, from $31.1 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $32.1 million in Q2 2021 to a low of $31.1 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 32.10 Mn |
| Dec 31, 2020 | 31.12 Mn |